Rosetta Genomics Announces Final New York State Approval for Rosetta Kidney Cancer Test By: Benzinga via Benzinga July 22, 2014 at 09:33 AM EDT Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics and ... Read More >>